ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-STEAP1 Antibody (A283124)

This product is discontinued

Anti-STEAP1 Antibody (A283124) has been discontinued and is no longer available.

View all STEAP1 Antibodies.

Name
Anti-STEAP1 Antibody
Description
Rabbit anti STEAP1 (C-Terminal)
Specificity
Rabbit anti Human STEAP1 antibody recognizes STEAP1, also known as six transmembrane epithelial antigen of the prostate. STEAP1 is a ~39 kDa protein and member of a family of cell surface serpentine transmembrane antigens of the prostate.STEAP1 is predominantly expressed in human prostate and is up-regulated in several cancer lines including prostate, ovarian, cervical, breast, testicular, bladder, colon and Ewing sarcoma. It is significantly expressed at cell-cell junctions and has been shown to be a target of human CD8 T cells. This indicates that it could be used as a potential target for cancer immunotherapy. This antibody does not cross-react with other STEAP-proteins.
Applications
WB, IHC-P
Reactivity
Human, Mouse, Rat
Immunogen
An 18 amino acid peptide located near the c-terminal region of human STEAP1.
Host
Rabbit
Clonality
Polyclonal
Isotype
IgG
Conjugate

Unconjugated

Purification
Affinity purification.
Concentration
1 mg/ml
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline with 0.02% Sodium Azide.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Synonyms
PRSS24, Six-transmembrane epithelial antigen of prostate 1, STEAP, STEAP1 protein
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.

Alternative products to Anti-STEAP1 Antibody (A283124)

Proteins predicted to interact with STEAP1

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
97.9% Relevancy Score
75% Relevancy Score
71.7% Relevancy Score
69.9% Relevancy Score
58.9% Relevancy Score
56.8% Relevancy Score
54% Relevancy Score
51.3% Relevancy Score
51.3% Relevancy Score